Monica Bhatia

Morgan Stanley Children's Hospital — United States

Medicine · Health Sciences

34h-index3.9kcitations226works11.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(111), Hemoglobinopathies and Related Disorders(79), Acute Lymphoblastic Leukemia research(58), Prenatal Screening and Diagnostics(39), Acute Myeloid Leukemia Research(36)

Publications226 total

G‐ <scp>CSF</scp> for Mobilizing <scp> CD34 <sup>+</sup> </scp> Cells in Individuals With <scp>SCD</scp> : A Word of Caution
American Journal of Hematology·2026Open Access
Outcomes Following Graft Failure and Second Subsequent Allogeneic Hematopoietic Cell Transplant in Patients with Sickle Cell Disease: A Multicenter Study
Transplantation and Cellular Therapy·2026
Pharmacokinetically-Adjusted Busulfan Dosing in Adults and Adolescents with Sickle Cell Disease or Transfusion-Dependent β-Thalassemia Treated with Exagamglogene Autotemcel
Transplantation and Cellular Therapy·2026
Long-Term Cardiac Function Remains Stable to Improved Following Curative Allogeneic Hematopoietic Cell Transplantation for Pediatric Sickle Cell Disease: A STAR Analysis
Transplantation and Cellular Therapy·2026
Acute GVHD Suppression Using Co-Stimulatory Blockade with Abatacept to Expand Non-Malignant Transplant: Preliminary Results from the Multicenter Ascent Trial
Transplantation and Cellular Therapy·2026
Long-term follow-up after mixed donor myeloid chimerism at 1 year post transplantation for sickle cell disease
Transplantation and Cellular Therapy·2026
Durable Clinical Benefits with Exagamglogene Autotemcel for over 5 Years of Follow-up in Transfusion-Dependent Thalassemia and Sickle Cell Disease with Recurrent Vaso-Occlusive Crises
Transplantation and Cellular Therapy·2026
<scp>RBC</scp> Alloimmunization Impacts Pediatric Sickle Cell Disease Transplant Outcomes and Transfusion Burden: A <scp>STAR</scp> Registry Report
American Journal of Hematology·2026
Long-term follow-up demonstrates durable clinical benefits of exagamglogene autotemcel for sickle cell disease with recurrent vaso-occlusive crises: Final results of climb SCD-121
Blood·2025Open Access
CRISPR-Cas12a gene editing of the HBG1/2 promoters leads to sustained normalization of total hemoglobin and increased fetal hemoglobin in patients with severe sickle cell disease: Updated Results from the RUBY trial
Blood·2025Open Access
Computational dissection of immune reconstitution across diverse conditioning regimens in adults with sickle cell disease undergoing allogeneic stem cell transplantation
Blood·2025
Distinct biological subtypes of chronic GVHD after pediatric hematopoietic cell transplantation
Blood·2025· 2 citedOpen Access
Improvements in health-related quality of life in patients with severe sickle cell disease after exagamglogene autotemcel
Blood Advances·2025Open Access
RISK FACTORS ASSOCIATED WITH READMISSION FOLLOWING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION AMONG CHILDREN
2025Open Access
It Takes a Village and More: First Report of Successful Allogeneic Hematopoietic Cell Transplantation for Hepatopulmonary Syndrome Associated With Chronic Active Epstein–Barr Virus Disease
Pediatric Blood & Cancer·2025
A Randomized Clinical Trial Evaluating Lactiplantibacillus Plantarum for the Prevention of GI aGvHD: A Report From the Children’s Oncology Group (ACCL1633)
Transplantation and Cellular Therapy·2025· 2 cited
Durable Clinical Benefits in Severe Sickle Cell Disease with Exagamglogene Autotemcel
Transplantation and Cellular Therapy·2025
Supply chain governance for sustainable solar energy system: impact of artificial intelligence
International Journal of Energy Technology and Policy·2025
Health-Related Quality-of-Life Improvements after Exagamglogene Autotemcel in Patients with Severe Sickle Cell Disease
Blood·2024· 1 cited
Durable Clinical Benefits with Exagamglogene Autotemcel for Severe Sickle Cell Disease
Blood·2024· 2 citedOpen Access
page 1 of 12Next →

Frequent Co-authors

Prakash Satwani(25), James H. Garvin(22), Mitchell S. Cairo(21), Diane George(18), Zhezhen Jin(17), Carmella van de Ven(13), Joseph E. Schwartz(12), M.B. Bradley(11), Erin Morris(9), Lee Ann Baxter‐Lowe(9), Lauren Harrison(9), Erin Morris(9), Mark C. Walters(8), R. Hawks(8), Michael A. Pulsipher(7), G. Del Toro(6), S. Foley(6), Olga Militano(6), Andrew L. Kung(6), Shalini Shenoy(5)